Patient demographics and baseline characteristics
| . | . | FCCam (n = 83) . | FCR (n = 82) . |
|---|---|---|---|
| Age, y (range) | 57 (51-64) | 57 (51-64) | |
| Sex, n (%) | F | 21 (25.30%) | 24 (29.27%) |
| M | 62 (74.70%) | 58 (70.73%) | |
| Binet score, n (%) | B | 66 (79.52%) | 66 (80.49%) |
| C | 17 (20.48%) | 16 (19.51%) | |
| B symptoms, n (%) | 19 (22.89%) | 14 (17.07%) | |
| ECOG score, n (%) | 0 | 64 (78.05%) | 54 (66.67%) |
| 1 | 16 (19.51%) | 26 (32.10%) | |
| 2 | 2 (2.44%) | 1 (1.23%) | |
| Beta-2-microglobulin, n (range) | mg/L | 3 (2-4) | 3 (3-4) |
| IGHV status, n (%) | mutated | 33 (39.76%) | 37 (45.12%) |
| unmutated | 50 (60.24%) | 45(54.88%) | |
| Del(11)q, n (%) | 17 (20.48%) | 16 (19.51%) | |
| IgG, g/L (range) | 6.66 (4.555-9.46) | 8.015 (5.963-9.545) | |
| IgA, g/L (range) | 0.945 (0.47-1.365) | 0.79 (0.46-1.11) | |
| IgM, g/L (range) | 0.225 (0.16-0.44) | 0.23 (0.16-0.425) | |
| CD38+ | 32.86% | 52.17% |
| . | . | FCCam (n = 83) . | FCR (n = 82) . |
|---|---|---|---|
| Age, y (range) | 57 (51-64) | 57 (51-64) | |
| Sex, n (%) | F | 21 (25.30%) | 24 (29.27%) |
| M | 62 (74.70%) | 58 (70.73%) | |
| Binet score, n (%) | B | 66 (79.52%) | 66 (80.49%) |
| C | 17 (20.48%) | 16 (19.51%) | |
| B symptoms, n (%) | 19 (22.89%) | 14 (17.07%) | |
| ECOG score, n (%) | 0 | 64 (78.05%) | 54 (66.67%) |
| 1 | 16 (19.51%) | 26 (32.10%) | |
| 2 | 2 (2.44%) | 1 (1.23%) | |
| Beta-2-microglobulin, n (range) | mg/L | 3 (2-4) | 3 (3-4) |
| IGHV status, n (%) | mutated | 33 (39.76%) | 37 (45.12%) |
| unmutated | 50 (60.24%) | 45(54.88%) | |
| Del(11)q, n (%) | 17 (20.48%) | 16 (19.51%) | |
| IgG, g/L (range) | 6.66 (4.555-9.46) | 8.015 (5.963-9.545) | |
| IgA, g/L (range) | 0.945 (0.47-1.365) | 0.79 (0.46-1.11) | |
| IgM, g/L (range) | 0.225 (0.16-0.44) | 0.23 (0.16-0.425) | |
| CD38+ | 32.86% | 52.17% |
ECOG indicates Eastern Cooperative Oncology Group.